Insider Transactions in Q4 2024 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 09
2024
|
Gerardo Hernandez Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,463
+50.0%
|
-
|
Dec 02
2024
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,084
-4.94%
|
$93,224
$86.4 P/Share
|
Dec 02
2024
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,084
+4.71%
|
$14,092
$13.28 P/Share
|
Nov 11
2024
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,458
-6.54%
|
$131,220
$90.04 P/Share
|
Nov 11
2024
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,458
+6.14%
|
$55,404
$38.46 P/Share
|
Nov 05
2024
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
6,750
-68.65%
|
$560,250
$83.83 P/Share
|
Nov 05
2024
|
Edward M Basile |
BUY
Exercise of conversion of derivative security
|
Direct |
6,750
+47.43%
|
$189,000
$28.12 P/Share
|
Nov 01
2024
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,083
-4.94%
|
$88,806
$82.64 P/Share
|
Nov 01
2024
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,083
+4.71%
|
$14,079
$13.28 P/Share
|
Oct 15
2024
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
8,625
-3.2%
|
$1,147,125
$133.5 P/Share
|
Oct 15
2024
|
Waleed H Hassanein President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,625
+10.93%
|
$112,125
$13.28 P/Share
|
Oct 01
2024
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,958
-1.45%
|
$443,700
$150.34 P/Share
|
Oct 01
2024
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,958
+4.1%
|
$115,362
$39.28 P/Share
|